163 related articles for article (PubMed ID: 6951470)
1. The immunopathology of acquired myasthenia gravis.
Engel AG; Sahashi K; Fumagalli G
Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
Engel AG; Lambert EH; Howard FM
Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
[TBL] [Abstract][Full Text] [Related]
3. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
[TBL] [Abstract][Full Text] [Related]
5. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
Sahashi K; Engel AG; Lambert EH; Howard FM
J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of acetylcholine receptor loss from the neuromuscular junction.
Engel AG; Fumagalli G
Ciba Found Symp; 1982; (90):197-224. PubMed ID: 6923808
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.
Engel AG; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis.
Fumagalli G; Engel AG; Lindstrom J
J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313
[TBL] [Abstract][Full Text] [Related]
10. Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect.
Mossman S; Vincent A; Newsom-Davis J
J Neurol Sci; 1988 Mar; 84(1):15-28. PubMed ID: 2835437
[TBL] [Abstract][Full Text] [Related]
11. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study.
Engel AG; Tsujihata M; Lindstrom JM; Lennon VA
Ann N Y Acad Sci; 1976; 274():60-79. PubMed ID: 1066997
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
Mossman S; Vincent A; Newsom-Davis J
Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
[TBL] [Abstract][Full Text] [Related]
13. Effect of myasthenic immunoglobulin G on motor end-plate morphology.
Tsujihata M; Satoh A; Yoshimura T; Motomura M; Takeo G; Matsuo H; Nakamura T
J Neurol; 2003 Jan; 250(1):75-82. PubMed ID: 12527996
[TBL] [Abstract][Full Text] [Related]
14. Immunopathologic events at the endplate in myasthenia gravis.
Ashizawa T; Appel SH
Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
[No Abstract] [Full Text] [Related]
15. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
Fazekas A; Komoly S; Bózsik B; Szobor A
Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
[TBL] [Abstract][Full Text] [Related]
19. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
[TBL] [Abstract][Full Text] [Related]
20. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
